Get started
Author

Lila Mékaoui

Observed names: L Mekaoui, L. Mekaoui, L. Mékaoui, Lila Mekaoui
Observed institutions: Université de Tours, Inserm, Université Paris Cité, Sorbonne Paris Cité, Centre Hospitalier Universitaire de Tours, Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Sainte-Anne, Hôpital Corentin-Celton, Institut de Psychiatrie et Neurosciences de Paris, Hôpitaux Universitaires Henri-Mondor, Centre Hospitalier Guillaume Régnier, Hôpital Albert-Chenevier, GHU Paris psychiatrie & neurosciences, Université Paris Descartes
ORCID: 0009-0001-9016-955X
Observed ORCID: 0009-0001-9016-955X
OpenAlex ID: A5113080890
Endogenous Retrovirus Type W GAG and Envelope Protein Antigenemia in Serum of Schizophrenic Patients
2008 · Hervé Perron, Lila Mekaoui, et al. · Biological Psychiatry · 137
Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme
2022 · Ludovic Samalin, Maud Rothärmel, et al. · International Journal of Psychiatry in Clinical Practice · 57
Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: Results from a multicenter study
2019 · Rachel Pascal de Raykeer, Nicolas Hoertel, et al. · Journal of Affective Disorders · 39
PDF
A meta-analysis of poststroke depression risk factors comparing depressive-related factors versus others
2020 · Rebecca Perrain, Lila Mekaoui, et al. · International Psychogeriatrics · 31
A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study
2020 · Nicolas Hoertel, Léa Rotenberg, et al. · Social Psychiatry and Psychiatric Epidemiology · 27
Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study
2019 · Elise Morlet, Jean-François Costemale-Lacoste, et al. · Journal of Affective Disorders · 23
PDF
Use of Esketamine Nasal Spray in Patients with Treatment‐Resistant Depression in Routine Practice: A Real‐World French Study
2024 · Ludovic Samalin, Lila Mekaoui, et al. · Depression and Anxiety · 20
PDF
Early effects predict trajectories of response to esketamine in treatment-resistant depression
2023 · Isaure Estrade, Anne-Cécile Petit, et al. · Journal of Affective Disorders · 18
PDF
Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study
2022 · Margaux Chene, Marina Sánchez-Rico, et al. · European Archives of Psychiatry and Clinical Neuroscience · 13
Hippocampal microstructural changes following electroconvulsive therapy in severe depression
2025 · A. Le Berre, D. Attali, et al. · Molecular Psychiatry · 11
Bright Light Therapy in the Morning or Midday for the Treatment of Nonseasonal Depression in Bipolar Disorder (LuBi): A Dose-Escalation Phase 1/2 Randomized Double-Blind Trial
2025 · Pierre A. Geoffroy, Sylvie Chevret, et al. · The Journal of Clinical Psychiatry · 10
Stratégies thérapeutiques prophylactiques dans la dépression unipolaire
2007 · Frédéric Limosin, Lila Mekaoui, et al. · La Presse Médicale · 8
Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series
2026 · Maud Rothärmel, Lila Mekaoui, et al. · European Journal of Psychotraumatology · 7
Depressive-, Cognitive- or Stroke-Related Risk Factors of Post-Stroke Depression: Which One Could Better Help Clinicians and Patients?
2021 · Rebecca Perrain, David Calvet, et al. · Neuropsychiatric Disease and Treatment · 7
PDF
Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study
2024 · Nicolas Hoertel, Marina Sánchez-Rico, et al. · European Archives of Psychiatry and Clinical Neuroscience · 6
Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray
2024 · Ludovic Samalin, Lila Mekaoui, et al. · International Journal of Psychiatry in Clinical Practice · 4
PDF
Patients’ health literacy in psychotic disorders
2007 · Ghassen Saba, Lila Mékaoui, et al. · Neuropsychiatric Disease and Treatment · 4
PDF
Is there an independant anti-suicidal effect of esketamine in treatment resistant depression?
2026 · Michel Danon, Gabriela Ostronoff, et al. · Journal of Affective Disorders · 3
Un atelier « mixte » de thérapie multifamiliale (TMF) pour les troubles des conduites alimentaires (TCA) de l’adulte
2023 · Sophie Criquillion-Doublet, Lila Mekaoui · Elsevier eBooks · 3
Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study
2026 · Maia Mallevays, Louise Fuet, et al. · medRxiv · 2
PDF
Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
2021 · E. Gaudre Wattinne, L. Mekaoui, et al. · European Psychiatry · 2
PDF
Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study)
2026 · Pierre-Michel Llorca, Anne Sauvaget, et al. · Therapeutic Advances in Psychopharmacology · 1
Real world clinical practice, efficacy and safety of esketamine nasal spray in MDD patients: the French ELLIPSE study
2025 · P.-M. Llorca, L. Mékaoui, et al. · European Psychiatry · 1
PDF
How adults with treatment resistant depression experience their first esketamine nasal spray treatment? Preliminary results from a French qualitative study
2024 · E. Manolios, J. Mathé, et al. · European Psychiatry · 1
PDF
e-santé dans la dépression : l’application mobile Bloom-up
2017 · Lila Mékaoui, Anne-Sophie Lombardi · Cairn.info · 1
Works count: 38
Citation count: 436
H-index: 10
I10-index: 11
Year
Topic
Type